Pharmaceutical Supply Chain; Industrials · medium ·
For pharmaceutical acquirers, drug-delivery packaging offers defensible revenues backed by patents and lengthy supplier qualification
The drug-delivery packaging sector is attracting increased M&A and investment due to its critical, stable role in pharmaceutical supply chains and high qualification barriers for new entrants. This makes packaging companies a robust and less volatile alternative to therapeutic plays for acquirers.
Part of the Healthcare & Life Sciences Opportunity Outlook, Korim's monthly analysis of emerging opportunities in this sector.
Part of the Industrial & Manufacturing Opportunity Outlook, Korim's monthly analysis of emerging opportunities in this sector.